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Abstract
Background: The use of minimally invasive ablative techniques in the management
of patients with low grade and localized prostate tumours could represent a
treatment option between active surveillance and radical therapy. Focal laser ablation
(FLA) could be one of these treatment modalities. Dosimetry planning and
conformation of the treated area to the tumor remain major issues, especially when,
several fibers are required. An effective method to perform pre-treatment planning of
this therapy is computer simulation. In this study we present an in vivo validation of
a mathematical model.
Methods: The simulation model is based on finite elements method (FEM) to solve
the bio-heat and the thermal damage equations. Laser irradiation was performed
with a 980 nm laser diode system (5 W, 75 s). Light was transmitted using a
cylindrical diffusing fiber inserted inside a preclinical animal prostate cancer model
induced in Copenhagen rats. Non-enhanced T2-weighted and dynamic gadolinium-
enhanced T1-weighted MR imaging examinations were performed at baseline and
48 hours after the procedure. The model was validated by comparing the simulated
necrosis volume to the results obtained in vivo on (MRI) and by histological analysis.
3 iso-damage temperatures were considered 43° C, 45° C and 50° C.
Results: The mean volume of the tissue necrosis, estimated from the histological
analyses was 0.974 ± 0.059 cc and 0.98 ± 0.052 cc on the 48 h MR images. For the
simulation model, volumes were: 1.38 cc when T = 43° C, 1.1 cc for T = 45°C and
0.99 cc when T = 50 C°.
Conclusions: In this study, a clear correlation was established between simulation
and in vivo experiments of FLA for prostate cancer.
Simulation is a promising planning technique for this therapy. It needs further more
evaluation to allow to FLA to become a widely applied surgical method.
Keywords: Prostate cancer focal laser ablation, thermal damage, bioheat transfer
simulation
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Natural history of prostate cancer (PCa) is characterized by the frequent multifocality
of the pathology. Cancer multifocality has been reported in 50 to 87% in contemporary
series of radical prostatectomies [1]. However, previous studies ([2], [3], [4]) have
shown that in case of multifocality localization, only the ‘index’ (i.e. the principal
focus) lesion volume is a predictive factor of progression. A 0.5 cc volume threshold is
currently accepted to define a lesion with clinically-significant size. This volume is
associated with a 10% risk of extra-capsular extension and metastasis [5].
Current therapeutic recommendations for localized prostate cancer consist in radical
options aiming to treat the prostatic gland in its totality (radical prostatectomy, radio-
therapy, brachytherapy, or HIFU). The use of minimally invasive ablative techniques in
the management of patients with low grade and localized tumours could represent a
treatment option between active surveillance and radical therapy. Focal laser ablation
(FLA) could be one of these treatment modalities. FLA is under development as a
minimally-invasive technique for in situ destruction of solid-organ tumours. Based on
the use of low-power laser, which delivers luminous energy using an adapted optical
system, FLA produces a coagulation necrosis zone, which volume can be controlled,
reducing the risk of damage to healthy adjacent structures.
First results of the use of FLA as management option for men with low risk PCa
were reported by the Toronto team ([6], [7]). Technical feasibility of the method was
proved and phase 1 clinical trial was conducted on 12 patients. The authors reported
that biopsies at 6 months in 67% patients were negative in the treated area.
The biological effects of laser energy depend on the laser wavelength, laser power,
the pulse duration, blood perfusion and both the optical and thermal properties of the
tissue involved [8]. Therefore, treatment monitoring is required in order to have pre-
cise information about the extent of thermal damage in tissues caused by laser intersti-
tial coagulation. Modeling laser-tissue interaction is a potent tool to help analyzing
and optimizing the parameters governing planned laser surgical procedures. Neverthe-
less, an adequate model with adequate accuracy remains to be developed.
Most suggested models depend on a large extent of simplifications of the real problem,
either in the geometry they offer or in the system of equations they use. Roggan et al. [8]
used Monte-Carlo (MC) simulation to simulate the use of multiple applicators, but this
method is limited to symmetrical geometries and has not been correlated to real ana-
tomic datasets. A similar study using finite difference method (FDM) to describe laser-
tissue interaction was proposed by Whelan et al. [9], but the authors did not include the
coagulation process with its irreversible changes in thermal tissues properties.
Some models used the bioheat equation and considered the role of the changes in
the tissue properties during temperature elevation processes. However, these models
presented deviations from the experimental results because of using inaccurate optical
tissues properties. Mohammed et Verhey [10] proposed a method based on finite ele-
ment modeling (FEM) and the combination of light and bioheat equations to deter-
mine the heat extent and damage distribution near main vessels. The authors checked
their model during in vitro experiments. The deviation between their model and the
experiment were 5% in x-direction and 20% in y-direction. They considered that the
main reasons behind this deviations lies with: 1) the use of inaccurate values for the
optical tissues properties, 2) The available memory limits which affect the performance
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used an absolute tolerance value of 0.01.
Very few modeling methods have simulated the behavior of in vivo laser-tissue inter-
action. The aim of this paper is to validate a 3D simulation model for calculating the
heat extent and estimating the volume of damaged tissue. Ground truth for the valida-
tion was available from the in vivo prostate cancer pre-clinical model.
Materials and methods
The model used to simulate focal laser-ablation (FLA) in in vivo prostate tissues uses
the FEM method to solve the bio-heat equation. Thermal prostate tissues properties
were reported from literature ([11], [12]).
Preclinical model
Investigations were conducted in accordance with accepted ethical and human prac-
tices, and approved by the local animal care committee at our institution. (Ethic Com-
mittee in Animal Experimentation of Lille University; agreement number: A59-35010
DHURE, file number:CEEA - 14-2009).
Preclinical model consisted in Dunning R3327-AT2 syngenic prostate adenocarcinoma
implanted (2× 10
6 cells) by subcutaneous injection in the flank of Copenhagen rat, 8
weeks of age or older (Harlan Laboratories TM). Ten rats were used in this study.
Experimental set up
Laser delivery was performed with a commercially available diode laser unit (Pharaon
980, Osyris, Hellemmes, France). This system delivers a maximum output of 15 W in a
CW or pulsed mode, at 980 nm. Laser light was transmitted through cylindrical diffus-
ing fiber (CDF) of 10 mm length with a 500 μm core diameter.
One hour before the procedure, a multi-spectral Magnetic Resonance Imaging (MRI)
acquisition was performed on the animals using a 7 Tesla MRI unit (Biospec, Bruker
BioSpin SA, USA). Acquisitions included T2 weighted (T2W) images and dynamic con-
trast enhanced T1 (DCE) images. The MR images were used for the pre-treatment plan-
ning of the procedure by defining the fiber trajectory (Figure 1.a). The axis and depth of
optimal fiber implantation were spotted on these image sequences. The purpose of this
identification was to avoid fiber implantation in a spontaneously necrotic area.
In order to induce local hyperthermia in the sub-cutaneous tumor, the laser proce-
dure was performed as follows: the CDF was inserted into the center of the tumor as
planned on the pre-treatment MRI. The power provided from the source was 5 Watt
with energy fluence of 1145 J/cm
2. The irradiance duration was 75 s. Measured initial
temperature of tissue was T0 = 37 ± 0.5°C. A thermocouple was used to measure the
maximum temperature at the tip end of CDF which was (91 ± 1) C°.
For the final positioning of the fiber, ultrasound imaging (US) was used to monitor
the insertion according to the MR planned trajectory. The distance between the skin
entry port and the end of the fiber diffusing part was measured on the US images.
This distance corresponded to the implantation depth measured on MRI.
48 hour after the procedure, another MR imaging including the same sequences
(T2W and DCE) were acquired. After this acquisition, the animals were euthanized
and tumors were removed. Histological analyses were performed and induced necrosis
volume measured (Figure 1.b, Figure 1.c and Figure 1.d).
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In the following sections, we will describe the different stages to construct the model:
Geometrical model
Starting from the MR images, a region of interest (ROI) was defined, enclosing both the
tumor and the fiber. We used the dimensions of the field of view of the MR images to
define the dimensions of the geometrical model. It consisted of cube of 70 × 70 × 20
mm
3. Then, the fiber trajectory seen on the MR images was used to define and to simulate
the fiber in the model. Tissue around the fiber in the model was considered homogenous.
Heat distribution
The absorption of light in tissue causes a local elevation in temperature. Tissue heat
transfer due to the energy of light deposited is described by the well known bioheat
transfer equation (Pennes equation):
CP ·
∂T(r,t)
∂t
−∇· (k ·∇T(r,t))=
wb · CP · [Tb − T(r,t)]+Q abs(r,t) +Q met
(1)
Figure 1 (a) Pre-treatment MR image of the rat. (b) Post-treatment MR image with the visualization of
the necrosis. The image is in a different plane than image (a). (c) The tumor after treatment and excision.
(d) Histological tumor slice with green filter to enhance the circular limits of the coagolative necrosis (black
arrows).
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Cp =C * r is heat capacity (J.mm
-3.°K
-1),
r is tissue density (g.mm
-3),
C is specific heat capacity of tissue (J.g
-1.°K
-1),
k is thermal conductivity of tissue (W.mm
-1.°K
-1),
wb is blood flow rate (ml.g
-1.min
-1),
Tb is the blood temperature,
t is time (s),
Qabs is the heat source (W.mm
-3),
Qmet is the metabolic heat source (W.mm
-3).
The precise evaluation of the optical parameters of prostate tissue remains a challen-
ging issue and all reported studies confirmed that they are heterogeneous and their
integration in a modeling process remains difficult and imprecise. For these reasons we
considered that the
Qabs term corresponds to the heat source and a constant value of 5 W.mm
-3 was
fixed in the model.
For the numerical application of these parameters for the pre-clinical model, we used
the values reported in [11]. They are summarized in table 1.
From the literature, in all cases the effects of metabolic heat source was considered
insignificant [13].
FLA model is based on the finite element method (FEM). The geometry of the
source was incorporated in the model as following: the starting point for the finite ele-
ment method is a mesh, which consists in a partition of the geometry into small units
of a simple shape (triangles or squares), called mesh elements (nodes).
The simulated laser source was considered as a cylinder, which has the same dimen-
sions of the source of laser used in the experiments.
The tissues were considered as a regular finite element grid of 70 × 70 × 20 mm
3
corresponding to the MR images. The initial temperature was set to 37°C.
The boundary conditions for the bioheat equation were:
T=T b for the cylindrical wall,
  n · k ·∇T=0 for all other surfaces.
Where   n is the direction of the heat flux.
To obtain a stable and convergent numerical solution, the GMRES (Generalized
Minimum RESidual) algorithm was used. GMRES is an iterative method introduced by
Table 1 Physical parameters of the AT-1 Dunning rat prostate used in the numerical
simulation extracted from reference [11] and reference [12] and corresponding to the
wave length l = 980 nm
Parameter Value
Specific heat capacity, C (J.g
-1.°K
-1) 4.20
Density, r (g.mm
-3) 0.999 × 10
-3
Thermal conductivity, k (W.mm
-1.°K
-1) 5.52 × 10
-4
Blood flow rate, wb (ml.g
-1.min
-1) 0.10
Frequency factor, Af (s
-1) 3.8 × 10
14
Activation energy, Ea (J.mole
-1) 1.084 × 10
5
Universal gas constant, R (J.mole
-1.°K
-1) 3.14847
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ing settings: time steps were 0.5 s and convergence tolerance was set to 10
-3.
Thermal damage
Thermal damage in cells and tissue can be des c r i b e dm a t h e m a t i c a l l yb yaf i r s t - o r d e r
thermal-chemical rate equation, in which temperature history determines damage.
Damage is considered to be a uni-molecular process, where native molecules are trans-
formed into a denatured/coagulated state through an activated state leading to cell
death. Damage is quantified using a single parameter Ω, which ranges on the entire
positive real axis. It is calculated from the Arrhenius law ([15], [16]). Ω is dimension-
less, exponentially dependent on temperature and on time of exposure. It is calculated
from the Arrhenius law as:
 (r,t) =l n

c(r,0)
c(r,t)

=A f
 τ
0
exp

−Ea
R.T(r,t)

dt (2)
where C(r,0),C (r,τ) are the concentrations of the undamaged molecules at the begin-
ning and at time τ, respectively.
Af (s
-1) is the frequency factor,
Ea (J.mole
-1) is the activation energy,
R (J.mole
-1.°K
-1) is the universal gas constant, and
T(°K) is the temperature
The parameters: Af,E a, called the kinetic parameters, are temperature dependent and
can be determined by the experimental. Numerical values of these parameters for the
Dunning R3327-AT prostate tissues, which correspond to temperatures measured at
the tip end of the CDF, were reported in [12] (table 1).
Equation 2 indicates that the measure of damage (Ω) describes the probability of tis-
sue being destroyed. It is the logarithm of the ratio of the initial concentration of
undamaged tissue to the concentration once damage has accumulated, for the time
interval t = 0 to t=τ. Therefore, Ω = 1 corresponds to an irreversible damage of 100%
of the affected cells.
T h ed a m a g et h r e s h o l df o rt i s s u en e c r o s is is commonly selected as omega = 1 (a
damage concentration of 63% for a unimolecular system). When performing an Arrhe-
nius analysis, omega > 1 is assumed to correspond with an experimental endpoint-
typically a visible increase in light scattering, which makes the tissue appear whiter
than the necrotic tissue. The necrosis border corresponds to Ω =1 .
Model validation
In a previous study [17], we demonstrated the correlation (Pearson correlation index r
= 0.87) between MR imaging measurements of necrosis induced by interstitial laser
and histology measurements. In fact, the histological analysis of thermal damage after
48 h displayed the same ellipsoid shape as the one observed on MRI. Thus, to validate
the proposed simulation model, we compared the simulated results with the MRI and
histology observations.
Hyperthermia literature often cites 43 degrees Celsius (43° C) as the point at which
thermal damage occurs to tissues [18] but this value depends on the energy source. For
instance, with radiofrequency ablation, a temperature of 47° C is generally accepted [13].
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of simulated isotherm for each temperature was compared to the MRI and macro-
scopic volumes.
Numerical implementation
The mathematical model was implemented using the COMSOL MULTIPHYSICS V4.0
(COMSOL Inc., Palo Alto, USA) software. This Finite Element computer aided design
software specifies the Partial Differential Equations, variables, geometry and boundary
conditions.
Results
Figure 2 illustrates the resolution of the bioheat equation with a temperature map at the
end of laser irradiation (t = 75 s) time. The solution shape is elliptical with a principal
axis corresponding to the length of the diffusing tip. Figure 2 is available as a video; this
video demonstrates the temperature rise inside the tissues. (Additional file 1)
Table 2 presents the necrosis volumes for ten rats calculated on MR images and from
the histological analysis after 48 hours from the laser procedure. The mean volume of
the tissue necrosis, estimated from the histological analyses was 0.974 ± 0.059 cc and
Figure 2 The solution of the heat distribution equation at the time = 75 seconds.T h es o l u t i o ni s
elliptical and corresponds to the length of the diffusing tip of the fiber. This figure is available as a video.
The video demonstrates the temperature rise inside the tissues (Additional file 1).
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were: 1.38 cc when T = 43° C, 1.1 cc for T = 45°C and 0.99 cc when T = 50 C°.
Figure 3 depicts the thermal damage in tissues resulting from the simulation and cor-
responding to (Ω = 1). Figure 3 is available as a video; this video shows how thermal
damage occurs and grows in tissues in time around the laser fiber (Additional file 2).
At the 48 h MRI control, the necrosis edges were visible in T1-weighted Turbo
FLASH sequence without gadolinium enhancement. These limits corresponded to an
hypo-intensive border. Lesions induced by FLA have a prolate spheroid shape. Figure 4
shows the simulated necrosis corresponding to the iso-damage Ω = 1. The necrosis is
merged with the 48 h MR image to highlight the correlation between the two results.
More details about the form of the thermal damage are available in as a video. This
video demonstrates the form of the thermal damage around laser fiber and how this
damage appears inside tissues (see Additional file 3).
Discussion
The concept of partial treatment or focal therapy for prostate cancer is recent and
controversial in the urological community owing to the frequency of tumor multifocal-
ity. However, in selected patients, this option could be an intersecting alternative for
low risk prostate cancers. Before the generalization of this concept, many issues have
to be addressed. First, accurate localization of the tumor is required. For this purpose,
ongoing work on the diagnosis and staging of tumors using multimodality imaging
(ultrasound, elastography, multiparametric MR,..) must be performed ([19], [20]). The
second issue is the treatment planning required to optimize therapy parameters to
ensure the optimal coverage of the area while sparing surrounding tissue. This issue is
challenging and still needs the development of dedicated dosimetric tools as it was the
case for radiotherapy and brachytherapy.
Indeed, in the first clinical trials of focal laser ablation of PCa [21], the authors
reported the following energies: 3260 J, 4014 J, 3516 J and 5900 J to obtain ablated
volumes: 4.5 cm
3,2 . 8c m
3,2a n d3 . 5c m
3 respectively. This represents energy volume
ratios of 724 J/cm
3,1 4 8 6J / c m
3, 1406 J/cm
3 and 1311 J/cm
3 respectively. This impor-
tant variability could be explained by an overtreatment of some areas.
Table 2 The necrosis volumes for ten rats calculated on the MR images and from the
histological analysis
Rat Necrosis volume on MRI at 48 h
(cm
3)
Histological necrosis volume
(cm
3)
Rat # 1 0.953 0.945
Rat # 2 0.970 0.950
Rat # 3 0.987 0.923
Rat # 4 0.946 0.990
Rat # 5 0.933 0.923
Rat # 6 0.967 0.941
Rat # 7 0.978 0.992
Rat # 8 0.989 0.988
Rat # 9 0.958 0.967
Rat # 10 1.121 1.125
Mean volume (cm
3) 0.98 ± 0.052 0.973 ± 0.059
The Pearson correlation index was r = 0.87 between the pathology volumes and the MRI volumes.
Marqa et al. BioMedical Engineering OnLine 2011, 10:45
http://www.biomedical-engineering-online.com/content/10/1/45
Page 8 of 12In a previous study for the establishment of an FLA protocol for prostate cancer,
where experiments were conducted on Dunning R3327-AT2 rat, we have obtained
robust parameters of power (5W) and time (75 s) to obtain a reproducible necrosis of
1c m
3 [16]. In this study, we were interested in the simulation of the FLA outcomes by
in vivo validation of a theoretical model. This generic model was already described and
used for different cancers. We have applied it to the pre-clinical model by defining the
accurate physical parameters.
The simulations were realized by the resolution of the heat diffusing equation and by
the modeling of thermal damage Ω. In this model, solving the Arrhenius equation for
time increasing temperature returns a relatively constant damage threshold value of 50
±1 ° Cf o rt=7 5se x p o s u r e( F i g u r e s2a n d3 ) .A lthough this model greatly simplifies
the understanding of thermal tissue damage by assuming a single first-order rate pro-
cess and to not directly modeling the energy of the laser light, it has been successfully
used to describe the threshold of tissue damage as a function of temperature and expo-
sure time.
Previous theoretical models of prostate treatment have generally assumed threshold
damage temperatures of 50°C. These values are based on studies involving exposure
Figure 3 Thermal damage in tissues resulting from the simulation and corresponding to (Ω =1 ) .
The thermal damage is available as a video stream. This video shows how the thermal damage occurs and
growing with the time around the laser fiber (Additional file 2).
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Peters et al. showed that the thermal-injury boundary can be predicted from a thresh-
old-maximum temperature of approximately 51 degrees C° or an equivalent Arrhenius
t(43) period of 200 minutes ([22], [23], [24]).
One limit of the current study stems from local tissue heterogeneities, uncertainties
in optical and thermal properties and blood perfusion rate in human prostate. These
heterogeneities observed from patient-to-patient and from base-to-apex of the prostate
complicate the prediction of FLA thermal damage. The last issue consisting in the
treatment monitoring could manage this limitation. The procedure could be guided by
images: temperature sensitive MR sequences or contrast-enhanced ultrasound elasto-
graphy. These control methods can either measure the temperature [25], the heat dis-
tribution or the tissue perfusion, but do not define the final necrosis. In fact, in
thermotherapy, the heat continues to spread after irradiation so that it is nearly impos-
sible to accurately identify the actually treated volume, without waiting several hours
after the end of the treatment.
On the other hand, good pre-treatment planning does not guarantee a good treat-
ment. Indeed, the treatment is correctly achieved when the fibers are inserted in the
right positions and in the right directions. The shape of prostate is different between
Figure 4 Iso-surface of the thermal damage matched with the 48 hours MR image.M o r ed e t a i l s
about the form of the thermal damage are available as a video stream. This video demonstrates the form
of the thermal damage around laser fiber and how this damage appears inside tissues (Additional file 3).
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makes difficult the correct mapping of the MR planned positions by the sole ultra-
sound guidance. Combination of these two modalities could be a solution to enhance
the accuracy of fibers insertion. Currently we are working on the integration of these
techniques in the treatment planning software to ensure the correct mapping of the
optimized positions.
Conclusion
Focal laser ablation of PCa is a promising therapy technique. It needs further more
evaluation and understanding of the heat extent in tissues to become a surgical
method applied in the routine hospitalization. In this paper we presented a numerical
simulation model of FLA and we validated it these simulations with in-vivo experimen-
tal results conducted on Dunning R3327AT-2 rat. A laser diode system attached to a
cylindrical diffusing fiber (CDF) was used to diffuse laser at 980 nm wavelength at
power 5 W during 75 seconds in tissues.
This approach could be a first step for a greater understanding of global impact of
laser-tissue interaction through the calculation of heat distribution and the thermal
damage. Post-laser thermotherapy tissue injury was quantified by calculating the ther-
mal damage (Ω). The threshold of irreversible cellular injury where Ω = 1 correspond-
ing to a temperature of 50°C.
Additional material
Additional file 1: Video 1. This video demonstrates the temperature rise inside the tissues and shows how the
heat distribution in tissues appears.
Additional file 2: Video 2. This video shows how the thermal damage occurs and grows in time around the laser
fiber.
Additional file 3: Video 3. This video stream demonstrates the form of the thermal damage around the laser
diffuser and how this damage appears inside tissues.
Acknowledgements
The authors wish to thank Pascal Servell for his careful review of the English language of the manuscript.
Author details
1Inserm (French National Institute of Health and Medical Research), U703, 152 rue du Docteur Yersin, 59120 Loos,
France.
2Université Lille Nord de France, F-59000 Lille, France.
3CHU Lille, F-59000 Lille, France.
Authors’ contributions
MFM: Carried out the numerical simulation and helped to draft the manuscript. PC: performed the animal
experimentations and discussed the clinical data. PN: Participated to the animal experimentations. SRM: Brought the
main idea of the work and helped in designing the study. NB: Designed the study and drafted the manuscript. All
authors read and approved the final manuscript
Competing interests
The authors declare that they have no competing interests.
Received: 23 April 2011 Accepted: 2 June 2011 Published: 2 June 2011
References
1. Mouraviev V, Mayes JM, Polascik TJ: Pathologic basis of focal therapy for early-stage prostate cancer. Nat Rev Urol
2009, 6(4):205-215.
2. Villers A, McNeal JE, Freiha FS, Stamey TA: Multiple cancers in the prostate. Morphologic features of clinically
recognized versus incidental tumors. Cancer 1992, 1(70):2313-2318.
3. Noguchi M, Stamey TA, McNeal JE, Nolley R: Prognostic factors for multifocal prostate cancer in radical
prostatectomy specimens: lack of significance of secondary cancers. J Urol 2011, 170:459-463.
Marqa et al. BioMedical Engineering OnLine 2011, 10:45
http://www.biomedical-engineering-online.com/content/10/1/45
Page 11 of 124. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM: Biological determinants of cancer progression in men
with prostate cancer. JAMA 1999, 21(15):1395-1400.
5. Bostwick DG, Waters DJ, Farley ER, Meiers I, Rukstalis D, Cavanaugh WA, et al: Group consensus reports from the
Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. Urology
2007, 70(6):42-44.
6. Lindner U, Weersink RA, Haider MA, Gertner MR, Davidson SR, Atri M, Wilson BC, Fenster A, Trachtenberg J: Image
guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol 2009, 182(4):1371-1377.
7. Lindner U, Lawrentschuk N, Trachtenberg J: Focal laser ablation for localized prostate cancer. J Endourol 2010,
24(5):791-797.
8. Roggan A, Mesecke-von Rheinbaben I, Knappe V, Vogl T, Mack MG, Germer C, Albrecht D, Muller G: Applicator
development and irradiation planning in laser-induced thermotherapy (LITT). Biomedizinische Technik 1997,
42:332-333.
9. Whelan WM, Wyman DR, Wilson BC: Investigations of large vessel cooling during interstitial laser heating. Medical
Physics 1995, 22(1):105-115.
10. Mohammed Y, Verhey JF: A finite element method model to simulate laser interstitial thermo therapy in
anatomical inhomogeneous regions. Biomed Eng Online 2005, 4(2):1-16.
11. Bischof JC, Smith D, Pazhayannur PV, Manivel C, Hulbert J, Roberts KP: Cryosurgery of Dunning AT-1 Rat Prostate
Tumor: Thermal, Biophysical, and Viability Response at the Cellular and Tissue Level. Cryobiology 1997, 34(42):69.
12. Xiaoming HE, Wolkers WF, Crowe JH, Swanlund DJ, Biscof JC: In Situ Thermal Denaturation of Proteins in Dunning
AT-1 Prostate Cancer Cells: Implication for Hyperthermic Cell Injury. Biomedical Engineering 2004, 32(10):1384-1398.
13. Chang IA, Nguyen UD: Thermal modeling of lesion growth with radiofrequency ablation devices. BioMedcial
Engineering OnLine 2004, 3(24):1-19.
14. Saad Y, Schultz MH: GMRES: A generalized minimal residual algorithm for solving nonsymmetric linear systems.
SIAM J Sci Stat Comput 1986, 7:856-869.
15. Niemz M: Laser-Tissue Interactions, Fundamentals and Applications. Springer-Verlag Berlin Heidelberg;, 1 1996.
16. Jankun J, Keck RW, Skrzypczak-Jankun E, Lilge L, Selman SH: Diverse optical characteristic of the prostate and light
delivery system: implications for computer modeling of prostatic photodynamic therapy. BJU International 2005,
95:1237-1244.
17. Colin P, Nevoux P, Marqa F, Auger F, Leroy X, Villers A, Puech P, Mordon S, Betrouni N: Focalized laser interstitial
thermotherpy at 980 nm for prostate cancer: treatment feasibility in Dunning R3327 AT-2 rat prostate tumor.
British Journal of Urology 2011.
18. Takahashi S, Tanaka R, Watanabe M, Takahashi H, Kakinuma K, Suda T, Yamada M: Effects of whole-body hyperthermia
on the canine central nervous system. Int J Hyperthermia 1999, 15(3):203-216.
19. Lopes R, Ayache A, Makni N, Puech P, Villers A, Mordon S, Betrouni N: Prostate Cancer characterization on MR images
using fractal features. Medical Physics 2011, 38(1):83.
20. Pallwein L, Aigner F, Faschingbauer R, Pallwein E, Pinggera G, Bartsch B, Schaefer G, Struve P, Frauscher F: Prostate
cancer diagnosis: value of real-time elastography. Abdominal Imaging 2008, 33:729-735.
21. Lindner U, Lawrentschuk N, Weersink RA, Davidson SRH, Raz O, Hlasny E, Langer DL, Gertner MR, Van der Kwast T,
Masoom HA, Trachtenberg J: Focal laser ablation for prostate cancer followed by radical prostatectomy: Validation
of focal therapy and imaging accuracy. European Urology 2010, 57(6):1111-1114.
22. Bhowmick S, Swanlund DJ, Coad JE, Lulloff L, Hoey MF, Bischof JC: Evaluation of thermal therapy in a prostate cancer
model using a wet electrode radiofrequency probe. J Endourol 2001, 15(6):629-640.
23. Peters RD, Chan E, Trachtenberg J, Jothy S, Kapusta L, Kucharczyk W, Henkelman RM: Magnetic resonance
thermometry for predicting thermal damage: an application of interstitial laser coagulation in an in vivo canine
prostate model. Magn Reson Med 2000, 44(6):873-883.
24. Van Nimwegen SA, L’Eplattenier HF, Rem AI, van der Lugt JJ, Kirpensteijn J: Nd:YAG surgical laser effects in canine
prostate tissue: temperature and damage distribution. Phys Med Biol 2009, 7(54):29-44.
25. Chen X, Saidel GM: Modeling of laser coagulation of tissue with MRI temperature monitoring. J Biomech Eng 2010,
132(6):064503.
doi:10.1186/1475-925X-10-45
Cite this article as: Marqa et al.: Focal Laser Ablation of Prostate Cancer: Numerical Simulation of Temperature
and Damage Distribution. BioMedical Engineering OnLine 2011 10:45.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Marqa et al. BioMedical Engineering OnLine 2011, 10:45
http://www.biomedical-engineering-online.com/content/10/1/45
Page 12 of 12